about
Putative contributors to the secular increase in obesity: exploring the roads less traveledA prospective evaluation of the timing of postoperative radiotherapy for preventing heterotopic ossification following traumatic acetabular fractures.Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: the impact of ethnic-specific normative data.Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users.An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans.A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapyComparative efficacy versus effectiveness of initial antiretroviral therapy in clinical trials versus routine careAn empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programsUniversal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America.Short-term discontinuation of HAART regimens more common in vulnerable patient populations.Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL studyYears of life lost due to obesity.Impact of organizational factors on adherence to laboratory testing protocols in adult HIV care in Lusaka, ZambiaAberrant drug-related behaviors: a qualitative analysis of medical record documentation in patients referred to an HIV/chronic pain clinicBeyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality.Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans.Radiographic severity of rheumatoid arthritis in African Americans: results from a multicenter observational study.Medication possession ratio predicts antiretroviral regimens persistence in Peru.HIV care visits and time to viral suppression, 19 U.S. jurisdictions, and implications for treatment, prevention and the national HIV/AIDS strategy.Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention.Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failureUnderutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patientsMeasuring retention in HIV care: the elusive gold standard.Multimorbidity patterns in HIV-infected patients: the role of obesity in chronic disease clustering.Estimating blood needs for very-low-birth-weight infants.Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.Effect of persistency of first-line HIV antiretroviral therapy on clinical outcomesBenefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users.The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture.Characteristics of an ambulatory palliative care clinic for HIV-infected patients.The association of clinical follow-up intervals in HIV-infected persons with viral suppression on subsequent viral suppression.Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosisIndustry funding and the reporting quality of large long-term weight loss trials.RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reductionCigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis.Missed visits and mortality among patients establishing initial outpatient HIV treatment.Church attendance in men who have sex with men diagnosed with HIV is associated with later presentation for HIV care.Gender differences in discontinuation of antiretroviral treatment regimens.
P50
Q22250989-488357A9-2EA8-4248-891B-C4712FDB7460Q30326968-642C3006-5142-40BA-89B8-6353A2F39C2EQ31005859-64BC00DC-82B7-4B36-A172-10F388E351B3Q31032925-83C3CE9C-4AB6-4311-9B6A-56E2BCE7AD43Q33419824-70E0B0C4-5422-425B-A46D-02514BAB8EF6Q33543151-1F564410-083C-4E07-B3E9-C9F4EBB8EE9BQ33689432-50227FB9-7F21-4E3D-BF2F-EE0D4B02B1B0Q33766361-EBDE6DE0-0668-4A45-B2F2-108418FCB88BQ33774697-927ACEAD-7427-4E91-B939-56F415D91591Q34062163-F5F213DE-6204-4F72-8BE8-6E4189F660CEQ34085103-C62AFEDE-865A-47F3-B5B4-695B8FB14780Q34113515-A6F617A1-7FAD-453B-8156-0FDECF730A82Q34140273-E4A1AF09-391F-4392-9872-8F53579CB5F8Q34169086-D8AD40F8-7DE3-4EAC-B0A4-9585803CAC13Q34253803-E3E7430D-F08C-4575-8694-9388AE9603B5Q34401510-C91BD546-F8AB-46DF-9AA2-DA7473E61B92Q34430170-85A97B3C-8C0E-4372-A074-28EADE181808Q34538156-87258523-772D-4C80-9611-F87FA2472599Q34642952-911CE074-FA4F-4470-BC46-B3E7D3C21880Q35009374-FE242AF8-F98F-4B01-BA55-008C9A49E6D0Q35082924-02FF3773-9108-4B0F-B848-7D09A8312B1EQ35613083-BF54D89A-5F10-4E71-AF81-E7895B9739E3Q36282679-9473C693-ADE2-456E-8D3A-08333F7D013FQ36379615-9BAA763F-FA41-4BF7-839E-74F04BE04CDAQ36428000-F1E46B9A-22BA-4CF3-AA2F-4A77F0C40307Q36429076-BDDD8989-1A3E-4FCE-8D6C-6045F6599FD9Q36640491-93B9168E-7433-4A75-BA3F-A07E73427F98Q36708737-6A73E368-787F-4091-9A46-EBCD18145DE2Q36715732-540BBFAF-29FD-4C1D-AC43-3959611FA9F5Q36952131-CEF807FE-9565-4184-9C05-C2B1C6E4396AQ37052607-F6BF3139-C3D4-407D-8A83-D18216255093Q37056028-21CBE780-ED1F-4927-9FBE-0C931815FBF1Q37086072-F51D04D7-EB62-48FA-88FE-E39D5EB54282Q37221438-956A259A-890A-46A5-A497-E4D3A6CA1A74Q37246642-7C2AE61C-BC74-4726-938D-749F1AD8F70AQ37264078-6C560657-B113-4A6D-ABED-CDC51B390B90Q37318673-B5338ADD-597F-4337-A88B-33C6E9345D65Q37332500-64EA936F-29B1-44B9-8006-DDD82C708ABBQ37411695-F9B75CFD-C7D4-44E2-92C6-683D239172FCQ37440855-DA4ED542-CFBB-4F3B-B6F2-76A2A519A8AA
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrew O Westfall
@ast
Andrew O Westfall
@en
Andrew O Westfall
@es
Andrew O Westfall
@nl
Andrew O Westfall
@sl
type
label
Andrew O Westfall
@ast
Andrew O Westfall
@en
Andrew O Westfall
@es
Andrew O Westfall
@nl
Andrew O Westfall
@sl
altLabel
Andrew O. Westfall
@en
prefLabel
Andrew O Westfall
@ast
Andrew O Westfall
@en
Andrew O Westfall
@es
Andrew O Westfall
@nl
Andrew O Westfall
@sl
P106
P21
P31
P496
0000-0002-0468-4695